(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

H.A.E.R.T.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

H.A.E.R.T.

ST13

US500000097482916

Class

44

Filing

97482916

Registration

7589652

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

12/03/2024

Classification

Registered

Trademark type

Word

Nice classes

44

Filing date

06/30/2022

Registration date

12/03/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/03/2024

Last transaction

12/03/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/13/2024

First use in commerce

08/13/2024

Drawing code

4

Owner type

16

Owner location

Vadodara, Gujarat, IN

Examiner

LATTUCA, FRANK J

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Alembic Pharmaceuticals Limited

Representatives

Matthew P. Hintz, Esq. LOWENSTEIN SANDLER LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticalspharmaceutical safetypharmaceutical misuse and pharmaceutical emergency proceduresall of the foregoing for the pharmaceutical containing acitretin

Publications

History of USPTO decisions and trademark events.

24 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/03/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/03/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/13/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/13/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/12/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/12/2024

IUAF

USE AMENDMENT FILED

09/10/2024

EISU

TEAS STATEMENT OF USE RECEIVED

09/10/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/11/2024

EX2G

SOU EXTENSION 2 GRANTED

07/11/2024

EXT2

SOU EXTENSION 2 FILED

07/11/2024

EEXT

SOU TEAS EXTENSION RECEIVED

07/11/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/13/2024

EX1G

SOU EXTENSION 1 GRANTED

01/11/2024

EXT1

SOU EXTENSION 1 FILED

01/11/2024

EEXT

SOU TEAS EXTENSION RECEIVED

01/11/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/18/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/23/2023

PUBO

PUBLISHED FOR OPPOSITION

05/23/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/16/2023

DOCK

ASSIGNED TO EXAMINER

04/16/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/20/2022

NWAP

NEW APPLICATION ENTERED

07/04/2022

Continuous trademark protection

Get notified about every new filing that threatens H.A.E.R.T. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.